ProShares UltraShort Nasdaq Biotechnology (BIS)

NASDAQ: BIS · IEX Real-Time Price · USD
19.49
-0.06 (-0.31%)
Nov 25, 2022 4:00 PM EDT - Market closed
Assets $5.85M
NAV $19.49
Expense Ratio 0.95%
PE Ratio n/a
Shares Out 300,000
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
1-Year Return +2.95%
Volume 29
Open 19.35
Previous Close 19.55
Day's Range 19.49 - 19.55
52-Week Low 18.82
52-Week High 35.64
Beta -1.38
Holdings 7
Inception Date Apr 8, 2010

About BIS

The ProShares UltraShort Nasdaq Biotechnology (BIS) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ. BIS was launched on Apr 8, 2010 and is managed by ProShares.

Asset Class Equity
Sector Biotech
Region North America
Stock Exchange NASDAQ
Ticker Symbol BIS
Issuer Website ProShares
Index Tracked NASDAQ / Biotechnology

Dividends

Ex-Dividend Amount Pay Date
Mar 25, 2020 $0.1057 Apr 1, 2020
Dec 24, 2019 $0.1653 Jan 2, 2020
Sep 25, 2019 $0.3247 Oct 2, 2019
Jun 25, 2019 $0.3852 Jul 2, 2019
Mar 20, 2019 $0.2542 Mar 27, 2019
Dec 26, 2018 $0.2715 Jan 3, 2019
Full Dividend History

News

2 ETFs to Watch for Outsized Volume on Internet & Inverse Leveraged Biotech

Inverse leveraged biotech ETF and internet ETF traded with an outsized volume on Friday.

Other symbols: PNQI
1 month ago - Zacks Investment Research

Cap-Weighting Crucial When Indexing Biotech

The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don't yet have steady revenue streams because their new drug or treatment is still in developm...

Other symbols: BIBIBBQ
10 months ago - ETF Trends